SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-230421
Filing Date
2014-06-09
Accepted
2014-06-09 16:30:52
Documents
3
Period of Report
2014-06-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d739104d8k.htm 8-K 18448
2 EX-99.1 d739104dex991.htm EX-99.1 7213
3 GRAPHIC g739104arca.jpg GRAPHIC 5331
  Complete submission text file 0001193125-14-230421.txt   34517
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 14899470
SIC: 2835 In Vitro & In Vivo Diagnostic Substances